SCHEMBL6600307

SCHEMBL6600307

Cc1nc[nH]c1C(O[SiH](c1ccccc1)c1ccccc1)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14152061 0.81 HTR3A (0.30)
SCHEMBL3879558 0.73
SCHEMBL7563856 0.73 ADRA2A (0.38)
SCHEMBL590533 0.69 AKT2 (0.35)
SCHEMBL3598196 0.68 ALOX5AP (0.34)
SCHEMBL14151705 0.68 CPA1 (0.34)
SCHEMBL1181592 0.67 S1PR3 (0.34)
SCHEMBL3421366 0.67 CHRM2 (0.35)
SCHEMBL3598537 0.67 KDM4E (0.36)
SCHEMBL9347230 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120835-B2 Phosphoric acid ester derivatives DAIICHI SANKYO COMPANY LIMITED (JP) 2015-09-01 US disclosed
EP-2537831-B1 IMIDAZOLE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2014-12-03 EP disclosed
US-20140135292-A1 Phosphoric Acid Ester Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-05-15 US disclosed
EP-2727926-A1 PHOSPHORIC ACID ESTER DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-05-07 EP disclosed
US-8653126-B2 Imidazole derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-02-18 US disclosed
EP-2537831-A1 IMIDAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-12-26 EP disclosed
US-20120316170-A1 Imidazole Derivative DAIICHI SANKYO COMPANY LIMITED (JP) 2012-12-13 US disclosed
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 EP disclosed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 US disclosed
EP-1169320-A4 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2002-10-30 EP disclosed
EP-1169320-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG Chem Investment, Ltd. (KR) 2002-01-09 EP disclosed
WO-2000064891-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD. (KR) 2000-11-02 WO disclosed